Non-selective Cannabinoids
Agonists |
Cat. No. | Product Name / Activity |
|---|---|
| 3381 | AM 1172 |
| CB receptor partial agonist; also anandamide uptake inhibitor and FAAH inhibitor | |
| 1339 | Anandamide |
| Endogenous and non-selective CB agonist | |
| 1017 | Anandamide (in Tocrisolve™ 100) |
| Endogenous CB receptor agonist (in water-soluble emulsion) | |
| 1298 | 2-Arachidonylglycerol |
| Endogenous and non-selective CB agonist; potent GPR55 agonist | |
| 2500 | Bay 59-3074 |
| CB1/CB2 receptor partial agonist | |
| 3021 | Cannabigerol |
| Cannabinoid receptor partial agonist | |
| 3130 | Cannabinol |
| Cannabinoid receptor agonist; not psychoactive | |
| 2928 | CB 13 |
| Potent dual CB1/CB2 agonist | |
| 0966 | HU 210 |
| Highly potent cannabinoid receptor agonist | |
| 1342 | JWH 018 |
| Potent CB1 and CB2 agonist | |
| 2680 | O-2545 hydrochloride |
| High affinity, water-soluble CB1/CB2 agonist | |
| 1038 | WIN 55,212-2 mesylate |
| Selective high affinity CB2 agonist | |
Antagonists |
Cat. No. | Product Name / Activity |
| 1570 | (-)-Cannabidiol |
| Natural cannabinoid; GPR55 antagonist, weak CB1 antagonist, CB2 inverse agonist and AMT inhibitor | |
Other |
Cat. No. | Product Name / Activity |
| 5395 | Virodhamine trifluoroacetate |
| TFA salt of virodhamine, an endogenous cannabinoid receptor mixed agonist/antagonist | |
Neurodegeneration Research Product Guide
Our Neurodegeneration guide highlights over 275 products for neurodegeneration research.
Request copyDownload PDFPain Research Product Guide
Our Pain guide highlights over 280 products for Pain research.
Request copyDownload PDFCannabinoid Scientific Review
Our Cannabinoid review gives an overview of the pharmacological ligands used to study the cannabinoid CB1 and CB2 receptors.
Request copyDownload PDF